Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05278260 · ClinicalTrials.gov registry record · Early Phase 1
Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients
A Early Phase 1 study, sponsored by Stony Brook University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 24
- Enrollment target
NCT05278260 is a Early Phase 1 study that has completed, run by Stony Brook University. The registered enrollment target is 24 participants.
The verdict
NCT05278260, a Early Phase 1 study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients
Interventions
- DIETARY_SUPPLEMENT Control
- DIETARY_SUPPLEMENT Hydrogen tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2022-05-25 |
| Est. Completion | 2024-11-13 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05278260
The ClinicalTrials.gov registry entry for NCT05278260 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT05278260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05278260 about?
NCT05278260 is a clinical study titled "Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients". This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients
What is the current status of trial NCT05278260?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 24 participants. The study started on 2022-05-25. Estimated completion is 2024-11-13.
What interventions are being tested in trial NCT05278260?
The interventions under investigation include: Control (DIETARY_SUPPLEMENT), Hydrogen tablets (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05278260?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.